Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000899140-16-001191
Filing Date
2016-02-16
Accepted
2016-02-16 13:18:44
Documents
2
Group Members
CUBIST SYSTEMATIC STRATEGIES, LLCEVERPOINT ASSET MANAGEMENT, LLCPOINT72 CAPITAL ADVISORS, INC.STEVEN A. COHEN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 s16245896a.htm SC 13G/A 123720
2 JOINT FILING AGREEMENT s16245896b.htm EX-99.1 5714
  Complete submission text file 0000899140-16-001191.txt   131192
Mailing Address 85B PARK DRIVE MILTON PARK ABINGDON X0 OX14 4RY
Business Address 85B PARK DRIVE MILTON PARK ABINGDON X0 OX14 4RY 44-123-544-3939
Summit Therapeutics plc (Subject) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0114
Type: SC 13G/A | Act: 34 | File No.: 005-88759 | Film No.: 161425899
SIC: 2834 Pharmaceutical Preparations

Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

EIN.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A